HIG enters the final day of April with one of the most striking options-market signals in the past year — and it arrives right on the heels of a Q1 earnings print that sent the stock lower.
Options positioning at Hartford has swung to its most defensive reading in at least twelve months. The put/call ratio jumped to 1.07 on April 29 — more than three and a half standard deviations above its 20-day average of 0.40. That is the highest PCR reading of the past year, and it represents a near-tripling from where the ratio was trading just a week earlier. The message is clear: options traders scrambled for downside protection after Q1 results, which knocked the stock down roughly 2.1% on April 24 and a further 1.5% on April 29, leaving HIG at $136.64 — off about 1.1% on the week.
Short interest tells a different story, and the contrast is worth naming. Bears have indeed been rebuilding. SI rose 7.2% over the past week to roughly 2.1% of the free float — the highest reading since early April. That follows a sharp contraction through most of the month, when SI fell around 17% from late March. The borrow market gives shorts no particular obstacle: cost to borrow is just 0.35%, down a touch on the week, and availability remains extremely loose. The ORTEX short score is modest at 33.8, ranking in the 45th percentile. Short interest at this level is a nuisance, not a structural overhang.
The Street remained broadly constructive post-results, though targets edged lower rather than higher. Mizuho lifted its target by $1 to $159, keeping an Outperform. UBS and Barclays both trimmed — UBS to $155 from $157, Barclays to $156 from $159 — while maintaining Buy and Overweight ratings respectively. The mean price target sits at $149.90, about 10% above the current price, keeping a reasonable degree of implied upside intact. The bull case rests on sustained Employee Benefits margin outperformance and above-plan investment yields, while bears focus on a slowing P&C pricing cycle and the prospect of EPS growth decelerating below book-value-per-share growth — a dynamic that has historically pressured insurance multiples. The trailing PE runs at 10.1x and the price-to-book at 1.79x, both little changed on the week, suggesting the re-rating is happening at the earnings line rather than in the multiple.
Institutionally, the ownership base is anchored and passive-heavy — Vanguard and BlackRock together hold more than 25% of shares. BlackRock added a notable 1.7 million shares in Q1, the largest change among top holders. Insider activity over the past 90 days has been light in dollar terms at the individual trade level: a cluster of small routine sales from the Chief Risk Officer, General Counsel and Controller in early April involved fewer than $2,000 worth of shares combined. The net 90-day figure of roughly 249,000 shares is positive, though this appears to reflect awards and vesting activity rather than conviction buying. HIG's dividend score ranks in the 95th percentile — a standout factor that underpins longer-term institutional demand even when near-term earnings optics are under pressure.
Among close peers, ACGL had the roughest week, down 4.2%, while SIGI surged 9.1% — a notable divergence within the property and casualty space. TRV and ALL each fell around 0.9%-0.9%, broadly in line with HIG. The relative calm in most P&C names suggests the HIG softness this week was specific to its own print rather than a sector-wide de-rating.
The next earnings event is flagged for May 20. With the options market now at a twelve-month extreme for defensive positioning, the PCR trajectory heading into that date is the number to watch most closely.
See the live data behind this article on ORTEX.
Open HIG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
